Welcome to our dedicated page for WELL HEALTH TECH news (Ticker: WHTCF), a resource for investors and traders seeking the latest updates and insights on WELL HEALTH TECH stock.
WELL Health Technologies Corp. reports developments across a Canadian outpatient healthcare platform, digital health software and related technology-enabled services. The company operates a large owned clinic network in Canada and reports recurring updates on patient visits, Canadian Patient Services, primary care and specialty care performance, acquisitions, clinic transformation activity and financial results.
WELL’s news also covers WELLSTAR healthcare technology products, including electronic medical records, AI-powered clinical tools, patient engagement, eReferral and IT managed services. Other recurring themes include HEALWELL AI, CYBERWELL cybersecurity services, virtual cardiology through CardiologyNow, partnerships for remote cardiac monitoring, conference participation and financing capacity for the company’s healthcare operations.
WELL Health Technologies (WHTCF) has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026, as part of a planned transition.
Sutherland, who has over 20 years of senior financial leadership experience and has completed more than 50 acquisitions and divestitures, previously held CFO roles at Staples Canada, Enercare, KEYreit and United Purchasing Group of Canada. She has served on the board of WELL subsidiary WELLSTAR for the past year, gaining direct insight into WELL’s strategy and governance.
Long-serving CFO Eva Fong will step down from the CFO role and become a strategic Executive Advisor, supporting an orderly handover. WELL describes itself as Canada’s largest outpatient healthcare company, operating 275 clinics and supporting more than 5 million annual patient visits through its clinic network and technology platforms.
WELL Health Technologies (WHTCF) reports that its WELLTRUST™ database has surpassed 100,000 patient consents since launching in February 2026. Each consented WELL patient has agreed to be contacted about clinical trials and research studies that match their health circumstances. The milestone was reached organically through in-clinic enrollment using WELLSTAR's OceanMD platform, which embeds a revocable consent step into digital check-in and writes the record to the patient chart.
HEALWELL's DARWEN™ AI matches trial protocols to this standing, consented population to deliver pre-screened participants to sponsors. WELL and HEALWELL outline a three-phase roadmap targeting about one million consented patients, deeper EMR connectivity across roughly 275 clinics, new digital consent channels, and future U.S. and European expansion.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) redeemed early all of its outstanding 5.50% convertible senior unsecured debentures due December 31, 2026. On August 19, 2026, the company paid holders in cash and the debentures ceased trading and were delisted from the TSX.
The redeemed debentures, previously trading under symbol WELL.DB, had an aggregate principal of $70 million. Holders received $1,007.3333 per $1,000 principal, including $7.3333 of accrued interest. According to WELL Health, the redemption was funded with cash on hand, supported by its inaugural $150 million senior unsecured notes offering completed in July.
WELL Health (OTCQX: WHTCF) reported record Q2-2026 revenue of $400.4 million, up 12% year-over-year, led by Canadian Patient Services revenue of $151.6 million, up 32%. Adjusted EBITDA was $48.1 million (down 3%), with a 12% margin, impacted by prior-year Circle Medical deferrals.
Adjusted Gross Profit rose 12% to $178.4 million (44.6% margin). The company recorded a net loss of $7.8 million versus prior net income of $17.0 million, while Adjusted Net Income fell to $11.6 million ($0.04 per share). WELL closed the OID Group and UnionMD acquisitions, lifting its Canadian clinic network to 275 clinics and WELL Canada’s annualized Adjusted EBITDA run-rate to over $100 million, ahead of plan.
Subsequently, WELL completed a $150 million 6.875% senior unsecured notes offering due 2031 and supported WELLSTAR’s planned TSXV listing via an RTO and $50 million subscription receipts financing. The company raised 2026 revenue guidance to $1.58–$1.65 billion and Adjusted EBITDA guidance to $185–$195 million.
WELL Health Technologies (OTCQX: WHTCF, TSX: WELL) has appointed Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer, expanding its executive leadership as it scales what it describes as Canada's largest outpatient healthcare platform powered by software and AI.
Grimaldi, a legal and business executive with over 25 years of experience, will lead legal, compliance, corporate governance, privacy, regulatory affairs, enterprise risk management and M&A. Przybylski, a technology and digital transformation leader with more than 25 years of experience in data, cloud, AI and enterprise modernization, will oversee enterprise technology strategy, digital transformation, data and AI platforms, cybersecurity and shared technology services, supporting WELL's growth and innovation objectives.
WELL Health Technologies (OTCQX: WHTCF, TSX: WELL) will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 6, 2026. Management will discuss the results on a conference call and simultaneous webcast the same day at 5:30 PM ET (2:30 PM PT), hosted by Chairman and CEO Hamed Shahbazi and CFO Eva Fong.
Investors can join via North American toll-free number 1-800-717-1738, Toronto/local and international line 1-289-514-5100, or by registering for the webcast at the company’s events page. WELL describes itself as Canada’s largest outpatient healthcare company, operating about 270 clinics supporting over 5 million annual patient visits.
WELL Health Technologies (TSX: WELL, OTCQX: WHTCF) has closed its inaugural private placement of $150 million aggregate principal amount of 6.875% senior unsecured notes due July 15, 2031, issued at par under a trust indenture. The notes are direct senior unsecured obligations of WELL and rank equally with all its present and future senior unsecured indebtedness.
According to WELL Health, net proceeds are intended to fully repay its convertible debentures maturing in December 2026 and for general corporate purposes. The notes were placed privately with institutional investors in all Canadian provinces, are not qualified for public distribution in Canada, and are not registered under the U.S. Securities Act of 1933.
WELL Health (OTCQX: WHTCF, TSX: WELL) has priced a private placement of $150 million aggregate principal amount of senior unsecured notes due 2031, bearing interest at 6.875% per annum and issued at par under a trust indenture.
According to WELL Health, net proceeds are intended to fully repay its convertible debentures maturing in December 2026 and for general corporate purposes, extending its debt maturity profile to 2031 and supporting growth in Canada. The notes will be direct senior unsecured obligations ranking pari passu with other senior unsecured debt. Closing is expected on or about July 15, 2026, subject to customary conditions, with a syndicate led by BMO Capital Markets and several other dealers.
WELL Health (TSX: WELL, OTCQX: WHTCF) reported voting results from its June 16, 2026 annual general and special meeting. All director nominees listed in the May 8, 2026 circular were elected.
A total of 90,692,992 shares, representing 35.50% of outstanding common shares, were voted by proxy. Shareholders also approved all other matters considered at the meeting.
WELL Health (OTCQX: WHTCF) issued a corporate update on majority-owned Circle Medical, highlighting patient access growth and a legal resolution.
Circle Medical now serves 32 states, connects to 99 payers and ~14,000 health plans, has more than tripled commercially insured patient eligibility, and resolved a USAO billing matter for USD$3.3 million within prior provisions.